Abstract
Transscleral cyclophotocoagulation (TSCPC) is a minimally invasive laser procedure used to reduce intraocular pressure in patients with glaucoma. By selectively coagulating the ciliary body, TSCPC reduces the production of aqueous humour and lowers intraocular pressure. TSCPC can be performed using various laser delivery methods, including “pop”‐titrated (PT–CPC), “slow‐burn” (SB‐CPC), and micropulse techniques (MP‐CPC).MP‐TSCPC has been shown to be effective in lowering IOP in patients with mild to moderate glaucoma, but may be less effective in patients with more advanced glaucoma or those with higher baseline IOP levels. PT/SB‐CPC, on the other hand, has been shown to be effective in lowering IOP in patients with refractory glaucoma who have not responded to other treatment options. Although there is a lot of research on the efficacy and safety of TSCPC, there is still limited data available, particularly comparing different TSCPC techniques.The present talk will summarize our experience with different TSCPC techniques, including patient selection, potential risks and benefits.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
